Detalhe da pesquisa
1.
Clonal expansion and epigenetic reprogramming following deletion or amplification of mutant IDH1.
Proc Natl Acad Sci U S A
; 114(40): 10743-10748, 2017 10 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-28916733
2.
Glioma Groups Based on 1p/19q, IDH, and TERT Promoter Mutations in Tumors.
N Engl J Med
; 372(26): 2499-508, 2015 Jun 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-26061753
3.
The alternative lengthening of telomere phenotype is significantly associated with loss of ATRX expression in high-grade pediatric and adult astrocytomas: a multi-institutional study of 214 astrocytomas.
Mod Pathol
; 26(11): 1425-32, 2013 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-23765250
4.
The differential diagnosis of pilocytic astrocytoma with atypical features and malignant glioma: an analysis of 16 cases with emphasis on distinguishing molecular features.
J Neurooncol
; 115(3): 477-86, 2013 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-24057326
5.
Mutant IDH1 Expression Drives TERT Promoter Reactivation as Part of the Cellular Transformation Process.
Cancer Res
; 76(22): 6680-6689, 2016 11 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-27758882
6.
CDKN2A loss is associated with shortened overall survival in lower-grade (World Health Organization Grades II-III) astrocytomas.
J Neuropathol Exp Neurol
; 74(5): 442-52, 2015 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-25853694
7.
Gene expression profile identifies tyrosine kinase c-Met as a targetable mediator of antiangiogenic therapy resistance.
Clin Cancer Res
; 19(7): 1773-83, 2013 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-23307858
8.
PDGFRA amplification is common in pediatric and adult high-grade astrocytomas and identifies a poor prognostic group in IDH1 mutant glioblastoma.
Brain Pathol
; 23(5): 565-73, 2013 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-23438035